Image-01 (4064e892 4c7a 46a7 9114 3e2bf466e597 01)
Etodolac Tablet
Product Images NDC 83980-030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 83980-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ipca Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
400,100 (4064e892 4c7a 46a7 9114 3e2bf466e597 02)
This is a description for Etodolac Tablets, USP. It includes information on the dosage, packaging details, manufacturer, and storage instructions. The text also mentions that it is made in India and distributed by Unkhem Pharmaceuticals. The dosage is listed as 100 mg per tablet, with guidelines on the usual dosage. It also features a warning about poisonous substances and advises storing at a temperature between 20°C and 25°C. Additionally, it references a Hedcton Guide that likely provides accompanying information for the product.*
500.100 (4064e892 4c7a 46a7 9114 3e2bf466e597 03)
This text appears to be a description of a medication product. It mentions "Etodolac", which is a nonsteroidal anti-inflammatory drug. The product is in tablet form and the text includes information such as tablet count (100 tablets), dimensions (45x15mm), and distribution details. The content also seems to refer to a controlled room for production.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
